Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging study of K-828 for behavioral and psychological symptoms in Alzheimer's disease dementia
jRCT2080220883Phase 2
- Sponsor
- Kowa Company, Ltd.
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing K-828 with Placebo (2 arms).
02
Drugs
K-828
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCT2080220883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220883.